Accroding to the company, the Med-e-Monitor product provides patients with an individualized daily treatment regimen involving medication prompts and health status questionnaires. It also alerts the patient and the care coordinator if the wrong drug is about to be taken or if a drug is missed.
Additionally, InforMedix said the system captures side effect and adverse event information, provides instant alerts and recommendations for action to the patient and triggers e-mail alerts to care managers and physicians to prompt urgent interventions.
This announcement comes as the National Council for Patient Information and Education states that outpatient medication non-compliance rates average 50% and result in over 125,000 preventable deaths and unnecessary costs each year. In an effort to tackle this problem, Congress and the Food and Drug Administration have been working together to improve patient drug safety, culminating in the creation of a new, independent Drug Safety Oversight Board to better ensure safe drug administration to patients.
InforMedix developed the Med-eMonitor System with the aim of providing real-time medical management and patient communications for clinical drug trials and disease management markets.
Bruce Kehr, CEO of InforMedix, stated: Studies conducted in Congestive Heart Failure and Schizophrenia populations have shown that the Med-e-Monitor System provides medication compliance and care plan adherence rates in excess of 90%.
